FDA approves ENCELTO, a first-of-its-kind eye implant that slows vision loss in rare eye disease (IMAGE)

Scripps Research Institute

FDA approves ENCELTO, a first-of-its-kind eye implant that slows vision loss in rare eye disease

Caption

Eye image of a patient with macular telangiectasia type 2, showing tiny crystal-like deposits and abnormal blood vessels in the retina.

Credit

Scripps Research

Usage Restrictions

Can be used with related coverage and with credit

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.